Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

High-avidity cathepsin-G-specific CAR-T cells for the treatment of acute myeloid leukemia.

Blood·2026
Same author

Persistent IFN-I signaling inhibits mitochondrial oxidative metabolism in CD8<sup>+</sup> T cells during HIV-1 infection under cART.

Cellular & molecular immunology·2026
Same author

HEPLISAV-B Breaks Immune Tolerance and Induces HBV Control via CD4 T Cell-Dependent Mechanisms in a Chronic Hepatitis B Mouse Model.

bioRxiv : the preprint server for biology·2026
Same author

Depletion of plasmacytoid dendritic cells rescues HIV-reactive stem-like CD8<sup>+</sup> T cells during chronic HIV-1 infection.

Science translational medicine·2025
Same author

Persistent Type I Interferon Signaling Impairs Innate Lymphoid Cells During HIV-1 Infection Under Suppressive ART.

Viruses·2025
Same author

Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4- and PD-1-targeted immunotherapy.

Science translational medicine·2023
Same journal

Correction: Fukushima et al. Long-Term Immunogenicity of Rabies Pre-Exposure Prophylaxis in Japanese Adult Travelers: Comparison of Dosing Regimens. <i>Vaccines</i> 2025, <i>13</i>, 1169.

Vaccines·2026
Same journal

Access to Vaccines Among Asylum Seekers, Refugees, and Undocumented Migrants Across the Migratory Cycle in the European Union, European Economic Area, Switzerland and the United Kingdom: A Scoping Review.

Vaccines·2026
Same journal

Advances in Detection Methods for Human Respiratory Syncytial Virus Neutralizing Antibodies.

Vaccines·2026
Same journal

Insights from 25 Years of Measles and Measles-Rubella Vaccination Campaigns in the WHO African Region (2001-2025).

Vaccines·2026
Same journal

Post-Marketing Safety Surveillance of Influenza Vaccines in Anhui Province, China, 2016-2025.

Vaccines·2026
Same journal

Characteristics of Hypotonic-Hyporesponsive Episodes (HHEs) Following Childhood Vaccination: A 13-Year Analysis of Spontaneous Reports to the Dutch Pharmacovigilance Centre Lareb.

Vaccines·2026
查看所有相关文章

相关实验视频

Updated: Jun 11, 2025

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery
05:15

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Published on: September 27, 2021

1.3K

使用人性化小鼠模型推进人类疫苗开发.

Runpeng Han1,2, Lishan Su3, Liang Cheng1,2

  • 1Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan 430071, China.

Vaccines
|September 28, 2024
PubMed
概括
此摘要是机器生成的。

人性化小鼠 (hu-mouse) 模型通过模仿人类免疫反应,为测试人类疫苗提供了更好的方法. 本综述探讨了它们在疫苗开发中的使用,特别是针对HIV-1的疫苗,并讨论了未来的改进.

关键词:
艾滋病病毒-1 艾滋病病毒-1人类疫苗人类疫苗人性化的小鼠.传染病是一种传染性疾病.

更多相关视频

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

8.5K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.0K

相关实验视频

Last Updated: Jun 11, 2025

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery
05:15

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Published on: September 27, 2021

1.3K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

8.5K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.0K

科学领域:

  • 免疫学 免疫学 免疫学
  • 疫苗学 疫苗学 疫苗学
  • 临床前研究 临床前研究

背景情况:

  • 开发针对传染病的有效疫苗是全球卫生优先事项.
  • 传统的动物模型往往无法准确预测人类对疫苗的免疫反应.
  • 人性化小鼠 (hu-mice) 提供了一个有前途的解决方案,通过整合一个功能的人类免疫系统.

研究的目的:

  • 审查常用的人类小鼠模型及其优化方面的进展,以改善人类免疫反应.
  • 总结人类疫苗开发中人类小鼠的应用,特别关注HIV-1疫苗.
  • 确定疫苗研究中人类小鼠模型的剩余挑战和必要改进.

主要方法:

  • 对人类小鼠模型现有文献的审查.
  • 分析使用人类小鼠进行疫苗有效性和安全性测试的研究.
  • 讨论在小鼠中增强人类免疫系统复原的策略.

主要成果:

  • 人-小鼠模型为评估人类疫苗候选人提供了一个更相关的临床前平台.
  • 在优化人类小鼠以更好地模仿人类免疫反应方面取得了重大进展.
  • 在HIV-1疫苗开发中的应用突显了这些模型的潜力.

结论:

  • 人-小鼠模型对于弥合人类疫苗开发中的翻译差距至关重要.
  • 需要进一步改进,才能充分发挥人类小鼠在各种传染病疫苗测试中的潜力.
  • 优化的人类小鼠模型对于加速开发安全有效的人类疫苗至关重要.